Secukinumab is used in the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis.
How Secukinumab works Secukinumab is a monoclonal antibody. It exerts its effects by neutralizing the activity of a protein called IL-17A, which is responsible for the symptoms of psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Common side effects of Secukinumab include the common cold, diarrhea, and upper respiratory tract infections.
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100

Download Now